Uterine artery embolization assisted cesarean section for the prevention of postpartum hemorrhage in

来源 :第三届中华医学会“长三角介入放射学高峰论坛”暨肿瘤综合介入治疗新技术研讨会 | 被引量 : 0次 | 上传用户:besunqz
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Purpose: To investigate the safety and efficacy of uterine artery embolization (UAE) assisted cesarean section (C-section) for the prevention of postpartum hemorrhage (PPH) in patients with uterine scarring and/or placenta accrete.Materials and Methods: Twelve consecutive pregnant women (mean age: 31; range: 25-38 years) with uterine scarring and/or placenta accrete underwent UAE during C-section to prevent PPH.The left uterine artery was catheterized under fluoroscopic guidance prior to the operation.After the infant was delivered and the umbilical cord was clamped,bilateral UAE was performed with the placenta in situ,then the placenta was removed from uterine wall.The primary endpoints were the maternal and neonatal 30-day operative mortality and fetal morbidity.The secondary endpoints were the operative blood loss,Apgar score,and fluoroscopy time and radiation dose.Results: UAE assisted C-section was successful performed in all 12 cases.No cases of maternal or neonatal death were recorded.Refractory PPH occurred in 1 case which lead to a hysterectomy,postoperative histological examination revealed placenta invasion of the cervix.No other fetal operative complications occurred.The mean operative blood loss was 1411 ml (range: 600-3600).The Apgar score was 10 in 11 infants; 1 infant had a score of 5 at birth,but improved to 10 after cardiopulmonary resuscitation.The mean fluoroscopy time mean and radiation dose was 8.66 minutes (range: 4.35-15.2) and 86.1 mGy (30.2-105),respectively.Conclusion: UAE assisted C-section was safe and appears to be able to prevent PPH in patients with uterine scarring and/or placenta accrete.
其他文献
药剂科作为医院的重要组成部分,不仅承担着药品供应、门诊调剂、住院调剂、医院制工作等药品供应保障工作,还担负着临床药学、药学科研、保障患者安全用药等重要任务,既是业务技术科室又是职能管理部门。本文结合我们的工作,就药剂科在当今医院发展新形势下的重要性及发展前景做一简要阐述。
目的:加强抗菌药物临床应用监管,促进抗菌药物临床合理应用。方法:通过探讨抗菌药物临床应用监管中发现的问题,提出抗菌药物临床应用管理经验和意见。结果与结论:抗菌药物临床应用管理仍存在一些技术性问题,需进一步修善,以提高管理水平,促进抗菌药物临床合理使用。
目的:介绍我院静脉药物配置中心(PIVAS)的建立与应用情况,以及药师在PIVAS 的实践体会。方法:通过药师在PIVAS 的工作与体会,探讨PIVAS 的优点。结果:PIVAS 实施一年来,保证了静脉药物的配置质量和用药安全,药师发挥作用,推动临床药学发展,减少药品浪费,降低医疗成本,加强配置护士的职业防护,提高病区护士的工作效率。结论:静脉药物配置中心是一种先进的静脉配液技术和药学服务模式,同
医疗机构在落实药品网上集中采购中出现了药品信息维护不配套;价格调整频繁,人工筛选困难;停药、断药情况频频出现;做不到全部药品的网上采购等各类问题。本文给出建议,以期尽快找到解决的方法,使药品招标网上集中采购顺利落实。
探讨当前时期药剂科管理工作处在国家政策调整时期,广大医院药学人员面临药品零差价销售政策,结合当前情况如何解放思想,立足岗位优势去取得优益成绩,为医院建设添砖加瓦。
会议
会议
目的:探讨急性肠系膜缺血性疾病的早期诊断和治疗方法.方法:回顾分析我院收治的12例急性肠系膜缺血性疾病患者资料,肠系膜上动脉栓塞6例,肠系膜上静脉血栓6例.6例肠系膜上动脉栓塞中,2例行肠系膜上动脉支架植入术,2例行导管内尿激酶溶栓治疗,2例开腹手术.6例肠系膜静脉血栓形成患者行抗凝治疗.结果:1例肠系膜上动脉栓塞患者手术取栓加大范围坏死肠段切除术的患者术后死亡,余5例患者痊愈出院.6例肠系膜上静
会议
会议